Atlas Trials

A Study Of Zy-19489 Administered Via Oral Route To Investigate The Safety, Tolerability And Pharmacokinetics In Healthy Adult Human Subjects

Clinical trial NCT05206201 · COMPLETED

Trial details

NCT number
NCT05206201
Sponsor
Zydus Lifesciences Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malaria
Start date
2021-08-25
Primary completion
2022-01-21
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.